Trends in FDA Good Manufacturing Practice Warning Letters

Recent U.S. Food and Drug Administration (FDA) warning letters provide clues to pharmaceutical companies about how they can enhance their quality systems, improve their manufacturing processes and more effectively manage future FDA establishment inspections, say Rob Church and Steve Mahoney.


Download PDF Share Back To Listing
Loading data